Changing from bevacizumab to ranibizumab in age-related macular degeneration. Is it safe? von Karagiannis, Dimitrios A, Ladas, Ioannis D, Parikakis, Efstratios, Georgalas, Ilias, Kotsolis, Athanasios, Amariotakis, Giorgos, Soumplis, Vasileios, Mitropoulos, Panagiotis

Volltext